Nuclear medicine in Nantes at the SNMMI 2022 annual meeting. A movie on the Nantes nuclear medicine cluster is being shown throughout the SNMMI international congress being held in Vancouver from 11 to 14 June 2022. From bench to bedside: The uniqueness and maturity of the Nantes’ Nuclear medicine community have not escaped the attention of the SNMMI meeting organisers. The 2022 edition of this major annual event for the world’s nuclear medicine stakeholders is taking place in Vancouver from 11 to 14 June. France is the highlight country for this meeting. Several researchers and clinicians from Arronax Nantes‘ member teams, LabEx IRON and SIRIC ILIAD have come to present their work and meet their peers. They will also be seen on the big screen, as the main stakeholders in a 6-minute movie presenting the Nantes cluster dedicated to research and development in nuclear medicine. The movie will be broadcast at the congress on the SNMMI TV channel throughout the event and is available online on YouTube. Watch the video on YouTube In this video, Prof. Françoise Kraeber-Bodéré, head of the nuclear medicine department at Nantes University Hospital, reviews the history of nuclear medicine in Nantes, now one of the French leaders in this field. Drs Caroline Rousseau, head of the nuclear medicine department at the Institut de Cancérologie de l’Ouest (ICO), and Clément Bailly, nuclear medicine physician at the Nantes University Hospital, highlight the diversity and relevance of the clinical trials conducted in Nantes thanks to the new IMRAM imaging centre, to improve the diagnosis and treatment of cancers and develop theranostic approaches. The strength of the Nantes community in nuclear medicine also lies in its basic and pre-clinical research activities, as shown by the CRCI²NA researchers. In their interviews, François Guérard illustrates the development of astatine chemistry and Sébastien Gouard presents the CIMA imaging facility. Being able to produce radiopharmaceuticals from A to Z, thanks in particular to the Arronax cyclotron and an on-site annex of the Nantes University Hospital’s Internal Use Pharmacy, is undoubtedly an additional asset for the site, says Mickaël Bourgeois, radiopharmacist at The Nantes University Hospital. Ferid Haddad, Director of GIP ARRONAX, gives the closing remarks, highlighting the multidisciplinary nature of the Nantes network and reaffirming, on behalf of all, the ambition of the community to continue to participate in the development of nuclear medicine. The video was shot in Nantes in January 2022 by the production firm Websedge. It was funded by the LabEx IRON, the GIP ARRONAX, and the SIRIC...
Lire plus »
ICOA conferences in june 2022 : thursday 02/06 at 10:30 IRD amphitheatre Prof. C. Turner (Lund University, Sweden) « Exploring sub- and supercritical fluids as green solvents in analytical-scale extraction and analysis » thursday 16/06 at 11:00 seminar room of ICOA Prof. I. Namboothiri (IIT Bombay, India) « Synthesis of Novel Carbocyclic and Heterocyclic Scaffolds from α-Functionalized Nitroalkenes » Contact: Marie-Aude HIEBEL and Vincent ROY ICOA – UMR 7311 / Université d’Orléans rue de Chartres B.P. 6759 – F-45067 Orléans Cedex 2, France mailto: vincent.roy@univ-orleans.fr / marie-aude.hiebel@univ-orleans.fr tel: + 33 (0)2 38 49 45 72 / + 33 (0)2 38 49 45...
Lire plus »
Thesis topic ARED-LCC CD35-ve Subject: Original chelates modified by peptides for hepatic tumour targeting: synthesis, characterisation, radiolabelling and in vitro/in vivo evaluation Application deadline: may 30, 2022 Starting date: october 2022 Funding: ARED/Ligue contre le Cancer (36 months) Contacts: Sandrine Cammas-Marion : sandrine.marion.1@ensc-rennes.fr Mickaël Bourgeois : mickael.bourgeois@univ-nantes.fr Nicolas Lepareur : n.lepareur@rennes.unicancer.fr...
Lire plus »
A gathering of world-renowned experts in radiopharmaceutical sciences in Nantes From 29th May to 2nd June 2022, around 400 researchers from the world over will gather at the Cité des Congrès in Nantes for the 24th edition of the “International Symposium on Radiopharmaceutical Sciences” (iSRS 2022). An occasion for radiochemists, radiopharmacists and clinicians to review the latest advances in their respective speciality fields and to share research on the development of nuclear medicine, with a particular focus on personalised strategies in the fields of oncology and neurology. Several members of the Nantes scientific community will be attending the conference. Organised jointly by members of the scientific community at the universities of Nantes, Rennes, Caen, Tours, the Centre de Lutte Contre le Cancer in Rennes and the CEA Paris-Saclay (Orsay), the Nantes edition of the International Symposium of the Society of Radiopharmaceutical Sciences (SRS) aims to present a comprehensive overview of current research in all aspects of radiopharmaceutical sciences: from drug synthesis based on the use of radiation for medical purposes to clinical studies on new targeted tracers, including pre-clinical studies, in vivo biodistribution and imaging. Gathering from around the globe, participants in the iSRS 2022 conference in Nantes will discuss the latest topics concerning the development of radiopharmaceuticals, including: neurology, radiometals, the theranostic approach, nanomedicine, the chemistry of Fluorine-18 and Carbon-11, the use of imaging in oncology, targetry, automation and microfluidics, therapies in oncology or bioconjugation technologies. Focus on young researchers! The Nantes edition of the iSRS conference is developing a wide range of initiatives targeting students and young researchers engaged in courses and career development in the area of radiopharmaceutical sciences. According to the local organising committee, “A pre-workshop for young researchers, led by young researchers assisted by more experienced scientists, will be held the day before the conference opens.” These young researchers will also be able to participate in the Radiopharmaceutical Sciences Olympiads, a video competition aiming to promote radiopharmaceutical sciences and technologies to the general public. The organisers add, “Participating in this competition will allow young researchers to enter into contact with globally-established radiopharmaceutical organisations.” In addition to regular scientific reports in the form of oral or poster presentations, PhD students will have an opportunity to present their research in a brief speech similar to the competition model “My doctoral thesis in 180 seconds”. Lastly, the SRS will provide grants to young researchers from the Americas and Asia to help them cover the cost of their subscription and fund their visit to Nantes. The Nantes scientific ecosystem is strongly involved in the development of nuclear medicine This ecosystem includes research laboratories, specialised hospital departments, cyclotron, training schemes and establishments, and innovation-driving SME. In the space of a few years, Nantes has created a robust network of multidisciplinary skills and expertise dedicated to the development of nuclear medicine. Academic stakeholders involved in nuclear medicine research and...
Lire plus »
Dear colleague, The radiobiology unit of SCK CEN, Mol, Belgium is looking for a research project leader to contribute to the research on effects of radiation therapy on human health with a particular focus on the central nervous and cardiovascular systems. This project leader will participate in radiation induced health research development of strategies to identify and implement (novel) sensitive technologies for assessing disease initiation and long-term health effects as well as (individual) responses to radiation therapy. Please find hereunder the full job description for more information. https://www.sckcen.be/en/careers/vacancies/research-project-leader-radiation-induced-health-effects Deadline to apply is 4th of May. Prof Sarah Baatout Head of Radiobiology Unit Belgian Nuclear Research Centre +32 14 33 27 29...
Lire plus »
